CellGenic nasal sprays are developed for laboratory research, formulation studies, and scientific exploration involving advanced delivery systems
QUALITY IMPROVEMENT P226 - ESOC25-1852 GEOGRAPHIC MODELING OF EVT ACCESS ACROSS CANADA DEMONSTRATES NEED TO LOWER DOOR-IN-DOOR-OUT TIMES Noreen Kamal 1 , Borna Baradaran-Noveiri 1 , Jack Barrie 2 , Jessalyn Holodinsky 2 , Andrew Demchuk 2 1 Dalhousie University, Halifax, Canada, 2 University of Calgary, Calgary, Canada Background and Aims: Timely access to endovascular therapy (EVT) for ischemic stroke patients is critical for optimal outcomes
The correct dosage will be determined by your healthcare provider based on your specific needs
A study by Garca-Collinot, G
Its quicker and more flexible, but you pay for the convenience